238
BRONCHIECTASIS DR.K.M.LAKSHMANARAJAN

BRONCHIECTASIS

Embed Size (px)

Citation preview

Page 1: BRONCHIECTASIS

BRONCHIECTASIS

DR.K.M.LAKSHMANARAJAN

Page 2: BRONCHIECTASIS

BRONCHIECTASIS

• CLINICAL DISCUSSION OF BRONCHIECTASIS

• PULMONARY FUNCTION TESTS• PHYSIOLOGY OF ONE LUNG

VENTILATION• ISOLATION OF LUNGS• ANESTHETIC MANAGEMENT

Page 3: BRONCHIECTASIS

CLINICAL DISCUSSION

• DEF • Abnormal ,persistent ,irreversible

dilation and distortion of medium sized bronchi (5th to 9th gen) by more than 2 mm

• May be due to bronchial distension as a result of chronic obstruction and recurrent infection

Page 4: BRONCHIECTASIS

PREDISPOSING FACTORS

• Congenital• Primary• Secondary • Mounier –kuhn syn-tracheo

bronchomegaly• William campbell syn-bronchomalacia• Pulmonary sequestration• Kartageners

synd(bronchiectasis,sinusitis,situs inversus)

• Young ‘s synd-idiopathic obstructive azoospermia

Page 5: BRONCHIECTASIS

• Yellow nail synd-lymphedema,yellow nails,pleural effusion

• Cystic fibrosis• Alpha 1 AT def• Hypogammaglobulinemia• Chandra-khetarpal synd-

levocardia,sinusitis,bronchiectasis with out ciliary abnomality

Page 6: BRONCHIECTASIS

ACQUIRED

• INFECTIONS-MEASLES,WHOOPING COUGH,BRONCHITIS,BRONCHIOLITIS,ENDOBRONCHIAL TB

• BRONCHIAL OBSTRUCTION-FOREIGN BODY,TUMOUR,LYMPHNODES,LA,ANEURYSM

• ASSOCIATED IMMUNE DISORDERS-ULCERATIVE COLITIS,SLE,RHEUMATOID ,ABPA

Page 7: BRONCHIECTASIS

TYPES

• CYLINDRICAL• SACCULAR(CYSTIC)• VARICOSE• FUSIFORM

Page 8: BRONCHIECTASIS

• LT LOWER LOBE COMMON• BECAUSE LT IS LONGER AND

NARROW• UPPER LOBE• INVOLVES POSTERIOR AND APICAL

SEGMENTS• COMMON IN TB,CYSTIC

FIBROSIS,ABPA

Page 9: BRONCHIECTASIS

DRY BRONCHIECTASIS

• BRONCHIECTASIS SICCA• ONLY HEMOPTYSIS PRESENT• NO SPUTUM PRODUCTION• TB

Page 10: BRONCHIECTASIS

MIDDLE LOBE(BROCK’S SYN)

• Recurrent atelectasis of RT middle lobe in the absence of endobronchial obst

• Which can lead to bronchiectasis and fibrosis

• Due to TB lymph node obstruction middle lobe bronchus

• RML-bronchus-narrow & slit like lumen• RML surrounded by nodes• RMLbefore bifurcation –runs longer

course• Lacks collateral ventilation

Page 11: BRONCHIECTASIS

PSEUDO BRONCIECTASIS

• TEMPORARY BRONCHIAL DILATATION OCCURING IN AN AREA OF LUNG AFFECTED BY PNEUMONIC CONSOLIDATION,TRACHEO BRONCHITIS/LUNG COLLAPSE

Page 12: BRONCHIECTASIS

COMPLICATIONS

• HEMOPTYSIS• METASTATIC ABSCESS• PNEUMOTHORAX• CORPULMONALE• AMYLOIDOSIS• RECURRENT PNEUMONIA• PYOTHORAX• LUNG ABSCESS

Page 13: BRONCHIECTASIS

CF

• PERSISTENT COUGH• RECURRENT COUGH• LARGE QUANTITY OF PURULENT

SPUTUM PRODUCTION• HEMOPTYSIS• PERSISTENT COARSE LEATHERY

CRACKLES• BRONCHIAL BREATHING• CLUBBING

Page 14: BRONCHIECTASIS

COUGH

• REFLEX ACT OF FORCEFUL EXPIRATION AGAINST CLOSED GLOTTIS

• BRONCHORRHOEA• IF THE QUANTITY >100ML /DAY• COPIOUS AMOUNT –CHANGES IN

POSTURE –DUE TO IRRITATION OF HEALTHY BRONCHIAL MUCOSA

• LARGE AMOUNT OF COLORLESS SPUTUM –ALVEOLAR CELL CARCINOMA

Page 15: BRONCHIECTASIS

• OFFENSIVE OR FOETID ODOUR SPUTUM

• LUNG ABSCESS• BRONCHIECTASIS• AMEBIC BACTERIAL INFECTION

Page 16: BRONCHIECTASIS

HEMOPTYSIS

• FRANK –BLOOD ONLY-CARCINOMA• SPURIOUS HEMOPTYSIS-SECONDARY

TO URI ABOVE THE LEVEL OF LARYNX

• PSEUDO HEMOPTYSIS-DUE TO PIGMENT,PRODIGIOSIN PRODUCED BY GRAM NEGATIVE ORGANISM ,SERRATIA MARCESCENS

• ENDEMIC HEMOPTYSIS –INFECTION WITH LUNG FLUKE (PARAGONIMUS WESTERMANI)

Page 17: BRONCHIECTASIS

SEVERITY OF HEMOPTYSIS

• Mild -<100 ml/day• Moderate 100-150 ml • Severe 200 ml • Massive >500 ml/day or >150 ml /hr or

100 ml /day for more than 3 days

Page 18: BRONCHIECTASIS

DYSPNEA

• AWARENESS OF ONE ‘S OWN RESPIRATION WHICH IS UNPLEASANT AND DISTRESSED

• NOT BREATHLESSNESS• BREATHLESSNESS-NOT

DISTRESSED,MAY BE PLEASURABLE(AFTER EXERCISE )

Page 19: BRONCHIECTASIS

DYSPNEA

• PROGRESSIVE DYSPNEA, • WORSENING COUGH, AND• PRODUCTION OF INCREASED

QUANTITIES OF PURULENT SPUTUM, • WITH ONSET OVER 1 TO 3 DAYS, • USUALLY AFTER AN UPPER

RESPIRATORY TRACT INFECTION, • DEFINES AN EXACERBATION OF

CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

Page 20: BRONCHIECTASIS

PND – IN RS

• BECAUSE OF POOLING OF SECRETIONS,

• GRAVITY-INDUCED DECREASES IN LUNG VOLUMES, OR SLEEP-INDUCED INCREASES IN AIRFLOW RESISTANCE

Page 21: BRONCHIECTASIS

ORTHOPNEA IN RS

• OCCASIONAL IN LUNG DISEASE • INSTANT ORTHOPNEA IS

PARTICULARLY CHARACTERISTIC OF THE RARE CONDITION OF PARALYSIS OF BOTH LEAVES OF THE DIAPHRAGM

Page 22: BRONCHIECTASIS

DYSPNEA GRADE- MODIFIED BORG CATEGORY SCALE

RATING INTENSITY OF SENSATION

 0 NOTHING AT ALL

 0.5 VERY, VERY SLIGHT (JUST NOTICEABLE)

 1 VERY SLIGHT

 2 SLIGHT

 3 MODERATE

 4 SOMEWHAT SEVERE

 5 SEVERE

 6  

 7 VERY SEVERE

 8  

 9 VERY, VERY SEVERE (ALMOST MAXIMAL)

10 MAXIMAL

Page 23: BRONCHIECTASIS

MRC GRADING OF DYSPNEA

1 Breathless only with strenuous exercise

2 Short of breath when hurrying on the level or up a slight hill

3 Slower than most people of the same age on a level surface orHave to stop when walking at my own pace on the level.

4 Stop for breath walking 100 meters orAfter a walking few minutes at my own pace on the level

5 Too breathless to leave the house.

Page 24: BRONCHIECTASIS

ROIZEN’S CLASSIFICATION

GRADE 0 NO DYSPNEA WHILE WALKING ON THE LEVEL AT NORMAL PLACE

1 I AM ABLE TO WALK AS FAR AS I LIKE ,PROVIDED I TAKE MY TIME

2 SPECIFIC STREET BLOCK LIMITATION- IHAVE TO STOP FOR A WHILE AFTER ONE OR TWO BLOCKS

3 DYSPNEA ON MILD EXERTION-I HAVE TO STOP AND REST GOING FROM THE KITCHEN TO BATH ROOM

4 DYSPNEA AT REST

Page 25: BRONCHIECTASIS

CHEST PAIN-CAUSES

• PLEURISY • INFLAMMATION OF OR TRAUMA TO

THE JOINTS, MUSCLES, CARTILAGES, BONES, AND FASCIAE OF THE THORACIC CAGE IS A COMMON CAUSE OF CHEST PAIN.

• REDNESS, SWELLING, AND SORENESS OF THE COSTOCHONDRAL JUNCTIONS IS CALLED TIETZE'S SYNDROME

• PHT

Page 26: BRONCHIECTASIS

INVESTIGATION-SCHIRMER TEST

• ASSESESSMENT OF CILIARY FUNCTION

• PELLET OF SACCHARINE PLACED IN ANT CHAMBER OF NOSE

• TIME TAKEN TO REACH THE PAHARYNX

• NORMALLY NOT MORE THAN 20 MINTS

Page 27: BRONCHIECTASIS

SPUTUM EXAMINATION

• 3 LAYERED SPUTUM • UPPER-FROTHY,WATERY• MIDDLE-TURBID,MUCOPURULENT• LOWER-PURULENT,OPAQUE

Page 28: BRONCHIECTASIS

XRAY CHEST

• RING SHADOWS• TRAM TRACK SIGN• GLOVED FINGER APPEARANCE• FIBROSIS• COR PULMONALE

Page 29: BRONCHIECTASIS

CT SCAN

• Thick sections –specific• Thin –sensitive• Proximal airway bronchiectasis-ABPA• Nodular bronchiectasis-Myco bact

avium

• Bronchography

Page 30: BRONCHIECTASIS
Page 31: BRONCHIECTASIS

SMOKING

• Contents• Carcinogens

Tar

Polynuclear aromatic hydrocarbons

Betanapthylamine

N-nitrosonornicotine

Benzopyrene

Nickel,arsenic

Polonium 210

Nitrosamines,hydrazine,vinyl chloride

Page 32: BRONCHIECTASIS

• Co carcinogens phenol,cresol,catechol• Tumor accelerator indole,carbazole

• 400 substances• Nicotine –ganglion stimulant /depressant

Page 33: BRONCHIECTASIS

NICOTINE • Increase both systolic and diastolic• Heart rate• Force of contraction• Myocardial oxygen consumption• Coronary blood flow• Peripheral vaso constriction

• CO-causes COPD,POLYCYTHEMIA,CNS IMPAIRMENT

Page 34: BRONCHIECTASIS

• Smoking index • SI=no of cigars /day ×total duration in

years• SI <100 –mild smoker• SI101-300-moderate smoker• >300-heavy smoker• Pack year• No of pack years=1 pocket of

cigarette/day×no of years(1 pack=20 cigars

• Risk 40 Times more if 2 packs /day for 20 years

Page 35: BRONCHIECTASIS

EXAMINATION

• Build• Nourishment• Dyspnea• Cyanosis• Anemia• Jaundice• Clubbing• Lymphadenopathy• Eyes• Pedal edema

Page 36: BRONCHIECTASIS

CYANOSIS

• Bluish discoloration of skin & mucous membrane due to increased quantityof reduced HB >5 gm/dl or >30 %of total HB and Pao2 <85% or due to the presence of abnormal HB pigments in blood perfusing these areas

• Central • Peripheral • differential

Page 37: BRONCHIECTASIS

CYANOSIS

• Due to methemoglobinemia-remains brown after exposure to air

• But cyanosis –change to bright red

• Intermittent cyanosis – EBSTEINS ANOMALY

Page 38: BRONCHIECTASIS

CYANOSIS IN RS

• HYPOXIA• CORPULMONALE• SILENT CHEST• ASPIRATION

Page 39: BRONCHIECTASIS

ANEMIA

• DUE TO HEMOPTYSIS • EXCESSIVE SPUTUM • PROTEIN LOSS• LOSS APPETETITE -MALNUTRITION

Page 40: BRONCHIECTASIS

JAUNDICE

• PULMONARY INFARCTION• DRUGS (ATT)• LIVER SECONDARIES• PNEUMONIA • CORPULMONALE-LIVER CONGESTION

Page 41: BRONCHIECTASIS

CLUBBING

• Selective bulbous enlargement of distal portion of digit due to incresed subungual soft tissue

• Normal angle between nail and nail bed 160 °(lovibond angle)

• Minimum duration need for clubbing manifestation -2- 3 weeks

• First appears in index finger

Page 42: BRONCHIECTASIS

GRADING OF CLUBBING

• 1-OBLITERATION OF ANGLE BETWEEN NAIL AND NAIL BED /POSITIVE FLUCTUATION TEST

• 2.PARROT PEAK APPEARANCE(AP DIAMETER INCREASED)

• 3.DRUMSTICK APPEARANCE• 4.HYPERTROPHIC OSTEOARTHROPATHY • SHAMROTH SIGN

Page 43: BRONCHIECTASIS

CLUBBING(HIPPOCRATES FINGERS)

• INDICATES UNDERLYING SUPPURATION /MALIGNANCY

• PACHYDERMOPERIOSTOSIS-PRIMARY FORM OF CLUBBING WITH SKIN CHANGES

• THYROID ACROPATHY-CLUBBING IN SEVERE THYROTOXICOSIS

• UNIVERSALLY PRESENT IN PANCOAST TUMOUR

Page 44: BRONCHIECTASIS

HYPERTROPHIC PULMONARY OSTEOARTHROPATHY

• PAINFUL SWELLING OF THE WRIST,ELBOW,KNEE ,ANGLE,WITH RADIOLOGICAL EVIDENCE OF SUBPERIOSTEAL NEW BONE FORMATION

• FAMILIAL /IDIOPATHIC

Page 45: BRONCHIECTASIS

HPOA

• UNIVERSALLY PRESENT IN PANCOAST TUMOUR

• OTHERWISE CALLED AS

Pierre Marie-Bamberger syndrome

Page 46: BRONCHIECTASIS

THEORIES OF CLUBBING

• Neurogenic –vagal stimulation –vasodilation and clubbing

• Humoral- GH,PTH,estrogen ,bradykinin –vasodilataion

• Ferritin – decreased ferritin in systmic circulation causes dilatation of AV anastomosis and hypertrophy of distal terminal phalanx

• Hypoxia –persistent hypoxia –opening of AV fistula • SHUNT THEORY• PLATELET DERIVED GROWTH FACTOR-latest /most

acceptable

Page 47: BRONCHIECTASIS

PSEUDO CLUBBING

• Hansen’s disease-due to resorption of tissue

• Vinyl chloride worker-focal tissue reaction

• Leukemia –tissue infiltration• Hyperparathyroidiam –bone resorption

Page 48: BRONCHIECTASIS

EYES

• Horners synd-pancoast tumour• iridocyclitis-TB/collagen vascular

disease• Phlycten –TB• Chemosis –sv syndrome • Choroid tubercle –TB • Papilledema –copd /svc obstruction• Color blind-ethambutol(red green color)

Page 49: BRONCHIECTASIS

PEDAL EDEMA

• CORPULMONALE• PROTEIN LOSS IN SPUTUM

Page 50: BRONCHIECTASIS

PULSE

• Wave form felt by finger ,produced by cardiac cycle ,which traverses the arterial tree in peripheral direction

• Pulsus paradoxus• Exaggerated reduction in strength of pulse during

normal inspiration or exaggerated inspiratory fall in systolic pressure of more than 10 mmhg during normal breathing

• CARDIAC TAMPONADE • Constrictive pericarditis• COPD /ACUTE SEVERE ASTHMA• SVC OBSTRUCTION

Page 51: BRONCHIECTASIS

• REVERSE PULSUS PARADOXUS• Insp rise in arterial pressure• HOCM • IPPV• AV dissociation

Page 52: BRONCHIECTASIS

NECK EXAMINATION-LYMPH NODE

• ROUND 0.5 CM DIAMETER FIRM –SIGNIFICANT

• LARGE FIXED –MALIG• HARD /CRAGGY MATTED-TB• VIRCHOW’S NODE –LT

SUPRACLAVICULAR NODE(TROSIER’S SIGN)

• PARIETAL PLEURA-AXILLARY NODE• RT LUNG/LT LOWER LOBE-RT SCN• LT UPPER LOBE-VIRCHOWS NODE

Page 53: BRONCHIECTASIS

PRESENCE OF VEINS

• SVC OBSTRUCTION

Page 54: BRONCHIECTASIS

EXTERNAL MANIFESTATION

• 1.ASTERIXIS –RESP FAILURE • TYPES OF RESP FAILURE

• 2.HALITOSIS - CONDITION OF HAVING STALE OR FOUL-SMELLING BREATH. SUPPURATIVE LUNG DISEASE

• GYNECOMASTIA-INH,DIGOXIN,BRONCHOGENIC CARCINOMA

• 3.HORNERS SYND-PANCOAST SYND

Page 55: BRONCHIECTASIS

TB MARKERS

• TINEA VERSICOLAR• LUPUS VULGARIS • ERYTHEMA NODOSAM • SCROFULDERMA • EPIDIDYMORCHITIS

Page 56: BRONCHIECTASIS

RES TRACT

• URT• LRT • 1.SUPRACLAVICULAR AREA• 2.INFRACLAVICULAR AREA• 3.MAMMARY REGION• 4.AXILLARY • 5.INFRA AXILLARY • 6.SUPRASCAPULAR • 7.INTERSCAPULAR • 8.INFRASCAPULAR

Page 57: BRONCHIECTASIS

TRACHEA

• TRAIL’S SIGN • UNDUE PROMINENCE OF CLAVICULAR

HEAD OF STERNOMASTOID ON SAME SIDE TO WHICH TRACHEA IS DEVIATED

Page 58: BRONCHIECTASIS

CHEST DEFORMITIES

• Flat chest –AP and transverse diameter ratio 1:2-TB /fibrothx

• Barrel chest-AP and TD 1:1-COPD (emphysema )

• Pigeon (pectus carinatum)-forward protrusion of sternum /adjacent costal cartilage-childhood asthma,marfans

• Pectus excavatum (funnel /cobblers chest)-exaggeration of hollowness of normal hollowness

• Harrisons sulcus-indrawing of ribs • Rickety rosary • Scorbutic rosary

Page 59: BRONCHIECTASIS

RS PROPER

• RR-THORACO ABD IN WOMEN • CHEST MOVEMENTS• RHYTHM OF RESPIRATION • TRACHEAL TUG-OLLIVERS SIGN-

ANEUYSM OF AORTIC ARCH• INSPIRATORY TRACHEAL DESCENT-

COPD

Page 60: BRONCHIECTASIS

NORMAL PERCUSSION NOTE

• CHRONIC BRONCHITIS• BRONCHIAL ASTHMA• INTERSTITAIL LUNG DISEASE• DIFFUSE EMPHYSEMA

Page 61: BRONCHIECTASIS

• TIDAL PERCUSSION

• TRAUBES PERCUSSION • Two parellel vertical lines• One from LT 6 th costochodral jn • Another From 9th rib in midaxillary line• LT costal margin • Boundaries RT –LT lobe of liver• LT –spleen• Above –LT lung• Below-LT costal margin• Content –fundus of stomach

Page 62: BRONCHIECTASIS

VESICULAR BREATH SOUNDS

• Low pitched ,rustling in nature produced by attenuating and filtering effect of lung parenchyma

• Normally no pause

Page 63: BRONCHIECTASIS

BRONCHIAL BREATH SOUNDS

• Loud high pitched with an aspirate and gutteral quality

• Duration of inspiration is shortened • Tubular• Cavernous• Amphoric

Page 64: BRONCHIECTASIS

ADDED SOUNDS

• Crackles • Non musical ,interrupted added sounds

of short duration • Explosive in nature• Types • Fine –loud ,short duration ,arise from

alveoli• Coarse –low pitched ,loud,arise from

bronchus and bronchioles

Page 65: BRONCHIECTASIS

CRACKLES

• Early inspiratory- chronic bronchitis• Mid insp –bronchiectasis• Late insp –

asbestosis ,fibrosis,ILD,pulm edema• Expiratory – chronic bronchitis,pulm

edema

Page 66: BRONCHIECTASIS

MECHANISM OF CRACKLES

• Bubbling of airflow thro secretions in bronchial level

• Sudden opening of successive bronchioles and alveoli with rapid equalisation of pressure-explosive sounds

• Crackles with out sputum-ILD• With sputum-parenchymal disease

Page 67: BRONCHIECTASIS

RONCHI

• Musical ,continous • Low pitched (sonorous)-from large airways• High pitched (sibilant)-smaller airways

Page 68: BRONCHIECTASIS

HAMMANS MEDIASTINAL CRUNCH

• Clicking ,rhythmical sound synchronous with cardiac cycle

• Mediastinal emphysema • Cavity –def• Gas containing space with a wall

thickness >1mm• Bulla <1mm thickeness

Page 69: BRONCHIECTASIS

ANATOMY OF RS

• LARYNX C3-C6• TRACHEA – C6-T5• 11 CM-15CM• 2-2.5 CM DIAMETER(OWN INDEX

FINGER DM)

• 2 BRONCHI • RT -2.5 CM , LT -5 CM • RT 10 SEG ,LT -10 SEG

Page 70: BRONCHIECTASIS
Page 71: BRONCHIECTASIS

FUNCTIONAL SUBSEGMENTS

Page 72: BRONCHIECTASIS

OXYGEN FLUX

• Amount of o2 leaving lt ventricle /min in arterial blood

• =CO*SAO2*HB% *1.31• 5000*98/100*15.6/100 *1.31• 1000 ml/min

Page 73: BRONCHIECTASIS

PFT

Page 74: BRONCHIECTASIS

PFT

• SPIROMETRY• HANDHELD SPIROMETER• BODY PLETHYSMOGRAPHY• N2 WASHOUT• HELIUM DILUTIONAL TECH• BED SIDE TESTS• ABG• V/Q SCAN• PERFUSION SCINTIGRAPHY

Page 75: BRONCHIECTASIS

WORLD SPIROMETRY DAY

Page 76: BRONCHIECTASIS

• STATIC TESTS• DYNAMIC LUNG• MUSCLES OF RESPIRATION• COMPLIANCE• DLCO

Page 77: BRONCHIECTASIS

GOALS OF PREOP - PFTS

• Quantify the severity • Follow up of disease• Observe response to treatment.• Predict likelihood of post-operative

complications

Page 78: BRONCHIECTASIS

INDICATIONS• > 60 yrs

• Evidence of chronic pulomonary disease

• Heavy smokers

• Patients with dyspnoea on exertion

• Morbidly obese pts.

• Patients with thoracic surgery

• Myasthenia gravis,GBS,polyneuritis.

• To see response of bronchodilators

• To assess degree of disability due to occupational lung diseases

Page 79: BRONCHIECTASIS

SPIROMETRY

• SPIROMETRY IS THE MEASUREMENT OF AIR FLOW INTO AND OUT OF THE LUNGS

• INVENTED BY JOHN HUTCHINSON • HE COINED THE TERM VITAL CAPACITY•  

Page 80: BRONCHIECTASIS

C/I TO SPIROMETRY

• Hemoptysis (spitting up blood from the lungs or bronchial tubes)

• Pneumothorax (free air or gas in the pleural cavity)

• Recent heart attack • Unstable angina • Aneurysm (cranial, thoracic, or abdominal) • Thrombotic condition (such as clotting

within a blood vessel) • Recent thoracic or abdominal surgery • Nausea or vomiting

Page 81: BRONCHIECTASIS

PREPARATION FOR SPIROMETRY

• SHOULD NOT HAVE EATEN HEAVILY WITHIN THREE HOURS OF THE TEST

• TO WEAR LOOSE-FITTING CLOTHING OVER THE CHEST AND ABDOMINAL AREA.

Page 82: BRONCHIECTASIS

SPIROMETRY

• That the patient’s trunk and neck remain erect during the maneuvers

• The patient looking straight forward during the entire test

• Without bending over (the latter not only affects the way the trachea is stretched, but may also lead to saliva dripping into the equipment).

Page 83: BRONCHIECTASIS

• FVC –minimum duration – 6 sec (3 sec for children <10 yrs)

• Children > 6 yrs –allowed • Max no of maneuvers-8• the largest and second largest FVC and

or FEV1 must not differ by more than 150 mL

Page 84: BRONCHIECTASIS

BED SIDE LUNG TESTS

• BREATH HOLDING (SABRASEZ)TEST• Pt asked to take deep breath and hold it

for as long as possible • >30 sec –normal • <15 sec-reduced vital capacity• Normal person – hold up to 1 min

Page 85: BRONCHIECTASIS

SNIDERS MATCH BLOWING TEST

• Lighted match stick held at 6 inches (15 cm ) from pt mouth

• Pt asked to blow out the match with out pursing lips

• Rough estimate of exp capacity /MBC• If cant –MBC <60 L/MIN OR FEV1 <1.6L• IF NOT ON 8 CMS DISTANCE –FEV

1<1L

Page 86: BRONCHIECTASIS

DEBONOS WHISTLE TEST

• INSTRUMENT HAS TUBE AND SIDE HOLES

• WHISTLE AT END • PT ASKED TO EXHALE AS

FORCEFULLY AS POSSIBLE INTO THE TUBE

• ESTIMATES PEFR UP TO 300 L/MIN

Page 87: BRONCHIECTASIS

WATCH AND STETHOSCOPE TEST

• Auscultation over the trachea during forced expiration

• Normal values -3-4 secs• >6 sec-obstructive airway

Page 88: BRONCHIECTASIS

HAND HELD SPIROMETRY

• FEV 1& PEFR• PEFR =HT (CM)-80* 5 • Normal PEFR 480-700 L/MIN(MALES)• 300-500 L//MIN(FEMALES)

Page 89: BRONCHIECTASIS

WRIGHT RESPIROMETER

• MEASURES MINUTE VOLUME /TIDAL VOLUME

• PEROPERATIVE USE

Page 90: BRONCHIECTASIS

TESTS FOR VO2 MAX

Page 91: BRONCHIECTASIS

EXERCISE TESTING-GOLD STANDARD

• For cardiopulmonary reserve• Normal VO2 max >40 ml/kg/min• 5 flights= >20 ml/kg/min-low post op

complications• 2 flights-vo2 =16 ml/kg/min• 1 flight = <10 ml/kg/min-inoperable • 10-15 ml/kg/min-high risk• 1 flight=20 steps ,6 inch ht

EXERCISE INCIDENCE OF CARDIOPULMONARY COMPLICATION

< 1 FLIGHT OF STAIRS 89%

<2 FLIGHTS 50%

<3 FLIGHTS 11%

Page 92: BRONCHIECTASIS

6MIN WALK TEST

• A practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians

• This test measures the distance that a patient can quickly walk on A FLAT, HARD SURFACE in a period of 6 minutes

• Used as a one-time measure of functional status of patients, as well as a predictor of morbidity and mortality

Page 93: BRONCHIECTASIS

• C/I TO 6MWT – UNSTABLE ANGINA • RESTING HR > 120 /MIN• BP > 180/100 MMHG • IF SAPO2 FALLS < 4 %-HIGH RISK FOR

PNEUMONECTOMY

Page 94: BRONCHIECTASIS

6MWT

• 180 FEET IN 1 MIN(6 MIN WALK DISTANCE 1080FT)=VO2 MAX 12 ML/KG/MIN

• <2000FT DISTANCE=VO2MAX <15ML/KG/MIN

Page 95: BRONCHIECTASIS

SHUTTLE WALK TEST

• If the repeat test is performed on the same day, 30 minutes rest should be allowed between tests

• A comfortable ambient temperature and humidity should be maintained for all tests. The walking track must be the same for all tests for a patient: Cones are placed nine metres apart.

• The distance walked around the cones is 10 metres.

Page 96: BRONCHIECTASIS
Page 97: BRONCHIECTASIS

SHUTTLE WALK TEST

• THE PATIENT SHOULD REST FOR AT LEAST 15 MINUTES BEFORE BEGINNING THE ISWT. RECORD: BLOOD PRESSURE.

• HEART RATE. • OXYGEN SATURATION. • DYSPNOEA SCORE• SPEED IS GRADULLY INCREASED

EVERY MIN• INABILTIY TO COMPLETE 25 SHUTTLES

–INDICATES VO2 MAX <15 ML/KG

Page 98: BRONCHIECTASIS

COOPER TEST

• Kenneth H. Cooper conducted a study for the United States Air Force in the late 1960s. One of the results of this was the Cooper test in which the distance covered running in 12 minutes is measured. Based on the measured distance, an estimate of VO2 max (in ml/min/kg) is

• VO2 MAX=d12-505/45

• where d12 is distance (in metres) covered in 12 minutes

Page 99: BRONCHIECTASIS

STATIC TESTS

Page 100: BRONCHIECTASIS

LUNG VOLUMES

• TV –volume of air inspired/exp at quiet breath -7-10ml /kg

• IRV-max volume of air that can be expired after normal inspiration

• 3200-3500 ml• ERV-max volume of air can be expired

after normal exp-1200 ml• RV-volume of air remaining in the lungs

after max expiration 1500-2100ml• Closing volume 15-20%of VC (volume of

gas expelled during Phase IV of single breath N2 test)

Page 101: BRONCHIECTASIS

Lung VolumesLung Volumes

IRV

TV

ERV

• 4 Volumes4 Volumes• 4 Capacities4 Capacities

• Sum of 2 or Sum of 2 or more lung more lung volumesvolumes

RV

IC

FRC

VC

TLC

RV

Page 102: BRONCHIECTASIS

CAPACITY

• Vital –max volume of air can expired after max inspiration-4000ml/2100-2600ml/m2

• TLC-total volume of air contained in the lungs at max inspiration

• IC-max volume of air can be inspired after normal expir-2000-2900 ml

• FRC-volume of air remaining in lungs after normal expiration 2300-3300ml

Page 103: BRONCHIECTASIS

DEAD SPACE

• Anatomical -150 ml(2 ml/kg)• Physiological –fraction of tidalvolume

not available for gas exchange

Page 104: BRONCHIECTASIS

CLOSING CAPACITY

• Volume at which small airways states to close down in the dependent lung

• Measured by single breath N2 wash out tech

• If CC rises above FRC –hypoxemia• CC increase –smokers,obesity,rapid

IVF ,chronic bronchitis• CC=CV+RV

Page 105: BRONCHIECTASIS

TLC

• Gold standard for measuring restrictive pattern

• Mild = <80% predicted • moderated <60 %• Severe <40%

Page 106: BRONCHIECTASIS

DYNAMIC TESTS

• FVC – after max inspiratory effort , exhales as forcefully and rapidly as possible

• Rate Of airflow indirectly relates to flow resistance properties

• Exhalation –atleast for 4 secs• Not to be interrupted by cough,glottic

closure

Page 107: BRONCHIECTASIS

• FEV 1 – FIRST SECOND OF FVC MANUEVER

• FEV 0.5 – 50%• FEV 1- 75-80%• FEV2 -94 %• FEV 3 -97%

FEV 1 SEVERITY OF OBSTRUCTION

<70% MILD

<60% MODERATE

<50% SEVERE

Page 108: BRONCHIECTASIS

FEV 1(LITRES) DEGREE OF OBSTRUCTION

3-4.5 NORMAL

1.5-2.5 MILD TO MODERATE

<1.0 HANDICAPPED

0.8 DISABILITY

0.5 SEVERE EMPHYSEMA

Page 109: BRONCHIECTASIS

PEFR

• MAX FLOW RATE MEASURED DURING FVC MANUEVER AT 0.1 SECS

• EXTRAPOLAGTED IN L/MIN

• USED TO MONITOR THERAPEUTIC RESPONSES

• NORMAL >500 LITRE/MIN• <200 LITRE/MIN-IMPAIRED COUGHING• PFR 200-1200 ML(MID EXP FLOW

RATE)-MEASURED BY HAND HELD SPIROMETRY/PNEUMATOGRAPHY

Page 110: BRONCHIECTASIS

MAX MID EXP FLOW RATE

• 25-75% OF EXP VOLUME • DOESN’T INCLUDE INITIAL HIGHLY

EFFORT DEPENDENCY• EFFORT INDEPENDENT• 4.5-5.0 LITRES/SEC

Page 111: BRONCHIECTASIS

MVV (MBC)

• Pt breaths as hard and fast as possible for 12 secs

• Extrapolated to 1 min• Litre/min• Decreased in obstructive disease• MVV=FEV1*35• =150-175 LITRES/MIN

Page 112: BRONCHIECTASIS

RESPIRATORY MUSCLE STRENGTH

• MAXIMUMSTATIC INSPIRATORY PRESSURE (PIMAX) NEAR RV –MEASURED

• MAX STATIC EXPIRATORY PRESSURE (PEMAX)-NEAR TLC

• NORMAL PIMAX = -125 CMH20• PEMAX = +200CMH20• < -25CMH2 0-SEVERE INABILITY TO

TAKE BREATH• <+40CMH20 OF PEMAX-SEVERE COUGH

IMPAIRMENT

Page 113: BRONCHIECTASIS

LUNG COMPLIANCE

• CHEST WALL • LUNG • TOTAL • COMPLIANCE = CHANGE IN

VOLUME /CHANGE INALVEOLAR - INTRATHORACIC PRESSURE GRADIENT

• NORMAL 200 ML/CMH20 IN UPRIGHT

Page 114: BRONCHIECTASIS

• CHEST WALL COMPLIANCE -200 ML/CM2

• TOTAL COMPLIANCE 100 ML/CMH20• MEASURED BY SWALLOWING LATEX

BALLOON IN ESOPHAGUS –CONNECTED TO CATHETER TO PRESSURE TRANSDUCER

Page 115: BRONCHIECTASIS

PULMONARY RESISTANCE

• MEASURED BY BODY PLETHYSMOGRAPH

• NORMAL RAW – 0.5 TO 2 CM/SEC

Page 116: BRONCHIECTASIS

DISTRIBUTION OF VENTILATION

• SINGLE BREATH N2 WASHOUT• MULTIPLE N2 BREATH• RADIO ISOTOPE TECHNIQUE(XE 133)

Page 117: BRONCHIECTASIS

PERFUSION

• RADIOISOTOPE • PULMONARY ANGIOGRAM

Page 118: BRONCHIECTASIS

MATCHING VENTILATION PERFUSION

• ABG• VQ SCAN• DEAD SPACE MEASUREMENT• INTRA PULMONARY SHUNT• NORMAL PA02-PaO2=8 mmhg

Page 119: BRONCHIECTASIS

DYSPNEA DIFFERENTIATION INDEX

• PEFR*PaO2/1000• LOW IN RESP DYSPNEA• %DDI OF PULMONARY =2.1±1.0• OF CARDIAC =4.0±1.4

Page 120: BRONCHIECTASIS

DLCO

• DEPENDS ON• CHARAC ALVEOLAR CAP MEMBRANE• EFFECTIVE SURFACE AREA OF GAS

EXCHANGE• VOLUME OF BLOOD IN ALVEOLAR

CAPILLARIES• CARDIAC OUTPUT• NORMAL 20-30 ML/MIN/MM

Page 121: BRONCHIECTASIS

• DLCO=CO(ML)/MIN/MMHG

PACO-PcCO

• CORRECTED DLCO

MEASURED DLCO  X (1.7 HB/(10.22+HB)

WHERE [HB] IS THE MEASURED HEMOGLOBIN CONCENTRATION (G/DL).

Page 122: BRONCHIECTASIS

PREDICTED DLCO

• (HT IN MTS)↑3 ×6(1- AGE-34)

100

Page 123: BRONCHIECTASIS

DIFFUSING CAPACITY

Decreased DLCO (<80% predicted)

Obstructive lung disease

Parenchymal disease

Pulmonary vascular disease

Anemia

Increased DLCO (>120-140%

predicted)

Asthma (or normal)

Pulmonary hemorrhage

Polycythemia

Left to right shunt

Page 124: BRONCHIECTASIS

OBSTRUCTIVE DISORDERS

• Characterized by a limitation of expiratory airflow• Examples: asthma,

COPD

• Decreased: FEV1, FEF25-

75, FEV1/FVC ratio (<0.8)

• Increased or Normal: TLC

• Scooped out appearance seen.

Page 125: BRONCHIECTASIS

RESTRICTIVE LUNG DISEASE

• Characterized by diminished lung volume due to:

• change in alteration in lung parenchyma (interstitial lung disease)

• disease of pleura, chest wall (e.g. scoliosis), or neuromuscular apparatus (e.g. muscular dystrophy)

• Decreased TLC, FVC

• Normal or increased: FEV1/FVC ratio

Page 126: BRONCHIECTASIS

LARGE AIRWAY OBSTRUCTION

• Characterized by a truncated inspiratory or expiratory loop

Page 127: BRONCHIECTASIS

UPPER AIRWAY OBSTRUCTION

Page 128: BRONCHIECTASIS

CRITERIA FOR ELECTIVE VENTILATION

• TV- < 2ML/Kg• VC-<15 ml/kg• FEV1-<50% predicted• FEV1/FVC-<50%• Maximum inspiratory pressure <20cm

of H20

Page 129: BRONCHIECTASIS
Page 130: BRONCHIECTASIS

PREOP EVALUATION

• THOROUGH HISTORY• CLINICAL EXAMINATION• INVESTIGATIONS

Page 131: BRONCHIECTASIS

EXTRA PULMONARY INTRATHORACIC SYMPTOMS

• PLEURAL EFFUSION• CHEST WALL PAIN• DYSPHAGIA(ESOPHAGUS)• SVC SYNDROME • PERICARDITIS• BRACHIAL PLEXUS • HOARSENESS • STRIDOR• HORNERS SYND

Page 132: BRONCHIECTASIS

EXTRA THORACIC METASTATIC SYMPTOMS

• BRAIN• BONE • LIVER• ADRENALS• GIT• KIDNEYS• PANCREAS

Page 133: BRONCHIECTASIS

EXTRA THORACIC NON METASTATIC SYMPTOMS

• Ectopic ACTH-CUSHING’S SYND• HYPONATREMIA• SIADH• HYPERCALCEMIA• CARCINOID SYND• EATEN LAMBERT SYND• HYPOGLYCEMIA• CLUBBING• THROMBOPHLEBITIS

Page 134: BRONCHIECTASIS

EATEN LAMBERT SYND

• ASSOCIATED WIT SMALL CELL LUNG CANCER

• AUTO IMMUNE DISEASE• ANTIBODY DIRECTED AGAINST AN

ANTIGEN CROSS REACT WITH VOLTAGE GATED CALCIUM CHANNLES INVOLVED IN ACH RELEASE

• PRESYNAPTIC DEFECT• EMG – INCREMENTAL PATTERN

Page 135: BRONCHIECTASIS

• PPO FEV 1%=PRE OP FEV1%×(1-% OF FUNCTIONAL LUNG TISSUE REMOVED /100)

Page 136: BRONCHIECTASIS

PRE OP PFT & RISK FOR PNEUMONECTOMY

TESTING PHASE PFT INCRESED RISK

WHOLE LUNG ABG HYPERCAPNIA IN ROOM AIR >45MMHG

SPIROMETRY FEV1<50 %

FEV1<2 L

MBC<50%

RV/TLC >50%

SINGLE LUNG TESTS SPLITLUNG FUCNTION PRED POST OP FEV1 <0.85 L>70 % BLOOD TO DISEASED LUNG

MIMIC POST OP CONDITIONS TEMP UNILATERAL OCCLUSION OF RT /LT MAIN STEM BRONCHUS

MEAN PAP >40MMHGSEVERE BREATHLESSNESSPACO2 >60 MMHG

LT PULMONARY ARTERY PaO2 <45MMHG

Page 137: BRONCHIECTASIS

MINIMAL PRE OP MEASUREMENTS OR PREDICTIONS FOR LUNG RESECTION

PFT UNITS NORMAL PNEUMO LOBEC SEGMENTAL RESECTION

FEV1 LITRES >4.0 >2.1-1.7 >1.2-1.0 >0.6-0.9

%(PRE OP) >80 OF FVC >50 >40 >40

LITRES(PPO) >0.9-0.8 >1 >0.6-0.9

FEV25-75% LITRES >2 >1.6 0.6-1.6 >0.6

FVC LITRES >5 >2 - -

MVV LITRES 100 >50 >40 >25

% PREDPREOP

100% 50% 40% 25%

Page 138: BRONCHIECTASIS

PFT UNITS NORMAL PNEUMO LOBEC SEGMENTAL RESECTION

DLCO %PPRE OP 100 >60 -

%POST OP PRED >40%

EXERCISE TESTING

STAIR CLINBING(PRE OP)

>10FLIGHTS >5 >3 >2

VO2 MAX(LIT/MIN) 2.8 >1 >1 >1

O2 SPO2 FALL WITH EXERCISE

NONE <3 <5 <5

PaO2 MMHG(PRE OP) >90 >80 >70 >60

Paco2 40 <45 <50 <55

Page 139: BRONCHIECTASIS

THREE LEGGED STOOL

• LUNG MECHANICS, PARENCHYMAL FUNCTION, AND CARDIOPULMONARY INTERACTION—SHOULD BE MADE FOR EACH PATIENT.

• THESE THREE ASPECTS OF PULMONARY FUNCTION FORM THE “THREE-LEGGED STOOL” THAT IS THE FOUNDATION OF PRETHORACOTOMY RESPIRATORY ASSESSMENT

Page 140: BRONCHIECTASIS
Page 141: BRONCHIECTASIS

RT HEART FAILURE/PHT• PVR >190 dymes/sec/cm

• LOUD P2

• LOSS OF NORMAL S 2 SPLIT

• S4

• HIGH PITCHED ESM

• X RAY

• DILATATION OF MAIN PULMONARY ARTERY

• FULLNESS OF APICAL PULM VESSELS

• ANTICLOCK WISE CARDIAC ROTATION

• LATERAL FILM – ENCROACHMENT OF RETROSTERNAL AIR SPACE

Page 142: BRONCHIECTASIS

CONT

• ECG• RAD• ENLARGEMENT OF RV• TALL R WAVE /S WAVE IN V2-V6• INVERTED T WAVE V1-V6• RA ENLARGEMENT• DEPRESSED ST V2-V6• PROMINENT P WAVE II,III• BIPHASIC P WAVE V1

Page 143: BRONCHIECTASIS

CONT

• ↑PAP,PVR,RA,RV

• PUMONARY DIASTOLIC MURMUR

• S3

• PARASTERNAL HEAVE

• DEPENDENT EDEMA

• TENDER LIVER

• ASCITES

• DISTENDED NECK VEINS

Page 144: BRONCHIECTASIS

BODE INDEX OF COPD

• Body Mass Index• Obstruction• Dyspnoea• Exercise Capacity

1 2 3 4

BMI <21 >=21

FEV1% PRED

>65 50-64 36-49 <35

MMRC DYSPNEA SCALE

0-1 2 3 4

6MWDISTANCE

>=350M 250-349 150-249 <149

Page 145: BRONCHIECTASIS

SHAPIRO’S POINT SCORINGCATEGORY POINTS

I.EXPIROTORY SPIRORAM

A.NORMAL %FVC+%FEV1/FEVC 150 0

100-150 1

<100 2

PRE OP FVC <20 ml/kg 3

POST BRONCHODILATOR FEVI/FVC<50% 3

II CVS NORMAL 1

CONTROLLED HT,MI WITHOUT SEQ >2YR

0

DYPNEA ON EXERTION,PND,PEDAL EDEMA,CCF,ANGINA

1

III CNS NORMAL 0

CONFUSION,OBTUNDATION,AGITATION SPASTICITY,BULBAR LESIONS 1

MUSCLE WEAKNESS 1

Page 146: BRONCHIECTASIS

SHAPIRO’S POINT SCORING

CATEGORY POINTS

IV ABG ACCEPTABLE 0

PACO2>50MMHG Pa02<60MMHG ON ROOM AIR

1

METAB PH ABNORMALITY >7.50 OR <7.30 1

V .POST OP AMBULATION WITH IN 36 HRS-SITTING AT BEDSIDE

0

EXPECTED COMPLETE BED CONFINEMENT FOR 36 HRS

1

TOTAL SCORE 7

Page 147: BRONCHIECTASIS

FORMULAS

EQUATION NORMAL VALUES

ALVEOLAR O2 TENSION

PAO2=(PB-47)FIO2-(PAO2/R)

110MMHG(FIO2=0.21)

ALVEOLAR –ARTERIOLAR O2 GRADIENT

A-aO2=PAO2-PaO2 <10MMHG

PaO2/PAO2 >0.75

ARTERIAL O2 CONTENT

CaO2=(SaO2)(HB×1.34)+PaO2(0.0031)

20ML/100ML BLOOD

MIXED VENOUS O2 CONTENT

CvO2=(SvO2)(HB×1.34)+PvO2(0.0031

15ML/100 ML

ARTERIAL-VENOUS O2 CONTENT DIFF

Ca02-Cv02 4-6ML/100ML

Page 148: BRONCHIECTASIS

EQUATION NORMAL VALUES

INTRAPULMONARY SHUNT Qs/Qt

(CcO2-CaO2)/CcO2-CVO2)

<5%

PHYSIOLOGICAL DEAD SPACE VD/VT

PaCO2-PECO2/PaCO2 0.33

O2 CONSUMPTION(VO2)

CO(CaO2-CvO2) 250ML/MIN

O2 TRANSPORT DO2

CO(CaO2) 1000ML/MIN

RESP QUOTIENT VCO2/VO2=R 0.8

Page 149: BRONCHIECTASIS

TYPES OF RESP FAILURE

• FOUR TYPES• TYPE III-POST OP ATELECTASIS• PAIN-IMPAIRED COUGHING

• TYPE IV-INADEQUATE BLOOD SUPPLY/PERFUSION TO INTERCOSTAL /RSPIRATORY MUSCLES IN SHOCK

Page 150: BRONCHIECTASIS

PRE OP INVESTIGATIONS • HB-ANEMIA,POLYCYTHEMIA• TC,DC-ACTIVE INFECTIONS• SPUTUM CULTURE-ANTIBIOTIC CHOOSE• SUGAR-HYPOGLYCEMIA(PARANEOPLASTIC

SYMPTOM)• UREA,CREAT-METASTASIS-TO KIDNEY• ELECTROLYTES-HYPONATRMIA,SIADH• LFT-RVF,ON ATT,METASTASIS• COAGULOPATHY ASSAY

Page 151: BRONCHIECTASIS

• X RAY CHEST• ECG-RV FAILURE,CORPULMONALE• HRCT• TREADMILL TEST• ECHO• V/Q SCAN• BRONCHOGRAM,FOB

Page 152: BRONCHIECTASIS

PRE OP PREPARATION

Page 153: BRONCHIECTASIS

WHY PRE OP PREPARATION • 3 REASONS FOR POST OP

COMPLICATIONS

• MAY BE DUE TO PRE OP/INTRA OP/POST OP

• 1.PRE OP RESP DYSFUNCTION –POSITIVE CORRELATION

• 2.THORACIC SURGERY PERSE CAN IMPAIR LUNG FUCNCTION

• 3.THORACOTOMY/UPPER ABDOMINAL INCISION-SEVERE PAIN –RESISIST DEEP BREATHING/COUGHING-ATELECTASIS

Page 154: BRONCHIECTASIS

REGIMEN

• 1.STOP SMOKING• 2.DILATE AIRWAYS• 3.LOOSEN SECRETIONS• 4.REMOVE SECRETIONS• 5.ADJUNCT MEDICATIONS• 6.INCREASED

EDUCATION/MOTIVATION

Page 155: BRONCHIECTASIS

STOPPING SMOKING

• 4-8 WEEKSTIME COURSE BENIFITS

12-24 HRS DECREASED CO,NICOTINE

48-72 HRS COHB normalised,CILIARY FUNCTION IMPROVES

1-2 WKS DECREASED SPUTUM PRODUCTION

4-6 WKS PFTS IMPROVES

6-8WKS IMMUNE FN & METABOLISM NORMALISES

8-12 WKS DECREASED OVERALL POST OP MORBIDITY /MORTALITY

Page 156: BRONCHIECTASIS

DISADVANTAGES OF STOPPING SMOKING

• ACUTE NICOTINE WITHDRAWL-ANXIETY

• HYPERSECRETORY AIRWAYS• BRONCHOSPASTIC STATE• INCREASED INCIDENCE OF DVT

Page 157: BRONCHIECTASIS

LATEST BRONCHODILATORS

• ACLIDINIUM BROMIDE• INDACATEROL • BOTH ARE INCREASING FEV1 & FVC

EFFECTIVELY

Page 158: BRONCHIECTASIS

LOOSENING SECRETIONS

• MECHANICAL NEBULIZER• 2-4 MICRONS PARTICLES

• ULTRASONIC NEBULISER• 0.8-1 MICRONS PARTICLES

Page 159: BRONCHIECTASIS

REMOVING SECRETIONS

• COUGHING• CHEST PHYSIOTHERAPY• FET• ACTIVE CYCLE BREATHING

Page 160: BRONCHIECTASIS

CHEST PHYSIOTHERAPY

• CUPPED HANDS• ELECTRIC VIBRATORS• 15-20 MINS SEVERAL TIMES/DAY• C/I-LUNG ABSCESS• HEMOPTYSIS• METASTASIS TO RIBS

Page 161: BRONCHIECTASIS

SEQUENTIAL POSITIONS FOR COMPLETE POSTURAL DRAINAGE

• 1) Upper lobes, anterior segments• 2) Upper lobe, posterior segment, right posterior

bronchus• 3) Upper lobe, posterior segment, right posterior

bronchus• 4) Right middle lobe• 5) Left lingula• 6) Lower lobes, apical segment• 7) Lower lobes, anterior basal segment• 8) Lower lobe, lateral basal segment• 9) lower lobes, posterial basal bronchus

Page 162: BRONCHIECTASIS
Page 163: BRONCHIECTASIS
Page 164: BRONCHIECTASIS
Page 165: BRONCHIECTASIS
Page 166: BRONCHIECTASIS
Page 167: BRONCHIECTASIS
Page 168: BRONCHIECTASIS
Page 169: BRONCHIECTASIS
Page 170: BRONCHIECTASIS
Page 171: BRONCHIECTASIS
Page 172: BRONCHIECTASIS

FET

• FORCED EXPIRATION STARTING FROM mid lung volume (50% of IRV) TO LOW LUNG VOLUME (RV)

• FOLLOWED BY RELAXATION OF DIAPHRAGMATIC BREATHING

• WIH OUT CLOSURE OF GLOTTIS• WITHOUT COMPRESSIVE PHASE OF

COUGH

Page 173: BRONCHIECTASIS

4 PHASES OF COUGH

• 1. THE INSPIRATORY PHASE• 2. THE CONTRACTIVE PHASE• 3. THE COMPRESSIVE PHASE • 4. THE EXPULSIVE PHASE

Page 174: BRONCHIECTASIS

• The inspiratory phase: the posterior cricoarytenoid muscle, innervated by the recurrent laryngeal nerves maximally abducts the vocal cords

• The contractive and compressive phases: the true and false vocal cords close tightly, with the false cords turned down, and the expiratory muscles (diaphragm, abdominal, chest wall, and pelvic floor muscles) contract, resulting in a dramatic increase in intrathoracic pressure.

Page 175: BRONCHIECTASIS

• The true vocal cords close first, followed by the false cords, then the aryepiglottic folds. The later two actions are mediated by the thyroarytenoid muscles.

• The final phase of the cough cycle is expulsive, with rapid expiration (peak flow of 25,000 cm/sec) and vibration of the vocal cords, supraglottic structures, and posterior glottis.

Page 176: BRONCHIECTASIS

LARYNGOSPASM

• Laryngospasm is a maladaptive exaggerated glottic closure reflex, mediated solely by the SLN ( tactile stimulation of the endolarynx) . Stimulation of the esophagus with acid or with sudden distension may cause laryngospasm

Page 177: BRONCHIECTASIS

ACTIVE CYCLE OF BREATHING TECHNIQUE (ACBT)

• can be performed in sitting, lying or postural drainage positions

• BREATHING Control (also called abdominal breathing)

• ¨ Rest one hand on your abdomen, keeping shoulders and upper chest relaxed and

• allow your hand to rise gently as you breathe in. (If you imagine air filling the abdomen

• like a balloon this may help)

Page 178: BRONCHIECTASIS

• ¨ Sigh out gently• ¨ Ensure shoulders remain relaxed• ¨ Over a few seconds, gradually

increase depth of breathing while maintaining relaxation

• Breathing control is an essential part of the cycle to allow rest.

Page 179: BRONCHIECTASIS

• Deep Breathing Exercises• ¨ Take 3 – 4 deep breaths in, allowing the

lower chest to expand• ¨ Try to ensure neck and shoulders remain

relaxed• ¨ At the end of the breath in, hold the air in

for 3 seconds• ¨ Let the air out gently

Page 180: BRONCHIECTASIS

TYPICAL CYCLE CONSISTS OF

Page 181: BRONCHIECTASIS

GE REFLUX PROPHYLAXIS

• H1-BRONCHO CONST• H2 –DILATATION • SO H2 BLOKERS CAN CAUSE

BRONCHO CONSTRICTION

Page 182: BRONCHIECTASIS

PRE OP DIGITALIZATION

• CONTRAVERSIAL• IF LVF PRESENT CAN BE USED• AF WITH RAPID VENTRICULAR RATE –

CAN BE USED

Page 183: BRONCHIECTASIS

PRE OP AF PROPHYLAXIS

• COMMON IN LT LUNG SURGERY• DILTIAZEM • AMIADARONE CAN BE USED• PULMONARY FIBROSIS• THYROID DYSFUNCTION

Page 184: BRONCHIECTASIS

PRE MED

• AVOID SEDATIVES• ANTACID PROPHYLAXIS TO BE GIVEN

Page 185: BRONCHIECTASIS

INTRA OP

Page 186: BRONCHIECTASIS

TIERED MONITORING TIERED SYST PT

CATEGORYGAS EXCHANGE

AIRWAY MECH

ETT POSITION PA PRESSURES

CARDIOVASCULAR STATUS

1.ESSENTIAL ONITORING IN ALLPTS

ROUTINE HELATHY PTS WITHOUT SPCL INTRA OP CONDITIONS

COLOR OF TISSUES,SPO2,PETCO2

FEEL BAG,STETH ,PIP,PETCO2

BAE,BALLOTABLE BALLON IN SUPRASTERNAL NOTCH,FOB AFTER LDP

NO NIBP,PULSE OXYMETRY WAVE FORM,ECG,PETCO2,ESOPHAGEAL STETH,±CVP, ±IABP

2.SPCL INTERMITTENT OR CONT MONITORING

HEALTHY PTS WITH SPCL PROCEDURES OR SICK PTS WITH ROUTINE PROCEDURE

+ ABG SPIROMETRY,INDIVIDUAL AND WHOLE LUNG

FOB IN SUPINE AND LDP

IF LOBECTOMY OR LUNG RESECTION

+IABP,CVP,PA CATHTER,±TEE

Page 187: BRONCHIECTASIS

TIERED SYST PT CATEGORY

GAS EXCHANGE

AIRWAY MECH

ETT POSITION PA PRESSURES

CARDIOVASCULAR STATUS

3.ADVANCED MONITORIING

SICK PTS WITH SPCL INTRA OP CONDITIONS

+QS/QT,VD/VT,VBGS

+AIRWAY RESISTANCE

FREQ FOB PA,Q,PVR,SVR,DAO2-DVO2

PA,TEE

Page 188: BRONCHIECTASIS

PA CATHETER

• MORMALLY IN RT PULMONARY ARTERY

• IF RT LUNG IS NON DEPENDENT,COLLAPSED-CO VALUE WILL BE LOW

• IF NON DEPEN LUNG VENTILATED WIT LARGE TIDAL VIOLUME ,PEEP,CPAP-LAP NOT CORRELATE WIT PCWP

• IF IT PAC IN DEPENDENT LUNG-EVEN WITH PEEP-LAP = PCWP

Page 189: BRONCHIECTASIS

INDUCTION

• 100 % O2 –PRE OXYGENATE • FENTANYL –UNTIL RR 8-10 /MIN• SODIUM THIO PENT-2-3 MG/KG• IPPV WIT MASK• NDMR • 1-3% SEVO• EYES –

CENTRAL,CONJUGATE,FIXED ,STARING,WITHOUT TEARS,NONDILATED PUPILS

• INTUBATED

Page 190: BRONCHIECTASIS

ADVANTAGE OF INHALATIONAL INDUCTION

Page 191: BRONCHIECTASIS

OPIOIDS/IV INDUCTION

Page 192: BRONCHIECTASIS

PRE OP EPIDURAL CATHETER

Page 193: BRONCHIECTASIS

PHYSILOGY OF SPONT VENTILATION WITH OPEN CHEST

• MEDIASTNAL SHIFT• PARADOXICAL RESPIRATION

Page 194: BRONCHIECTASIS

INTRA OP COMPLICATIONS

COMPLICATIONS ETIOLOGY

Hypoxemia

Intrapulmonary shunt during one-lung ventilation

Sudden severe hypotension Surgical compression of the heart or great vessels

Sudden changes in ventilating pressure or volume

Movement of endobronchial tube/blocker, air leak

Arrhythmias Direct mechanical irritation of the heart

Bronchospasm Direct airway stimulation, increased frequency of reactive airways disease

Massive hemorrhage blood loss from great vessels

Hypothermia Heat loss from the open hemithorax

Page 195: BRONCHIECTASIS

CAPNOMETRY IN OLV

• The end-tidal CO2 (PETCO2) is a less reliable indicator of the PaCO2 during OLV than during two-lung ventilation,

• and the PaCO2- PETCO2 gradient tends to increase during OLV.

• Although the PETCO2 is less directly correlated with alveolar minute ventilation during OLV, because the PETCO2 also reflects lung perfusion and cardiac output it gives an indication of the relative changes in perfusion of the two lungs independently during position changes and during OLV.

Page 196: BRONCHIECTASIS

• As the patient is turned to the lateral position the PETCO2 of the nondependent lung will fall relative to the dependent lung, reflecting increased perfusion of the dependent lung and increased dead space of the nondependent lung.

• However, the fractional excretion of CO2 will be higher from the nondependent lung in most patients owing to the increased fractionalventilation of this lung.

Page 197: BRONCHIECTASIS

IVF MANAGEMENT

• NO VOLUME FOR THIRD SPACE LOSS• TOTAL POSITIVE FLUID IN 1 ST 24 HRS

PERI OP –NOT EXCEED 20 ML/KG• CRYSTALLOIDS <3 L IN 1 ST 24 HRS• URINE OUT PUT >0.5 ML/Kg/HR –

UNNECESSARY• IF TISSUE PERFUSION NEEDED-

IONOTROPES

Page 198: BRONCHIECTASIS

OLV-INDICATIONS• Absolute

• Isolation of one lung from the other to avoid spillage or contamination

• Infection • Massive hemorrhage

• Control of the distribution of ventilation• Bronchopleural fistula• Bronchopleural cutaneous fistula• Surgical opening of a major conducting airway• giant unilateral lung cyst or bulla• Tracheobronchial tree disruption• Life-threatening hypoxemia due to unilateral lung disease

• Unilateral bronchopulmonary lavage

Page 199: BRONCHIECTASIS

OLV-INDICATIONS

• Relative• Surgical exposure ( high priority)

• Thoracic aortic aneurysm• Pneumonectomy• Upper lobectomy• Mediastinal exposure• Thoracoscopy

• Surgical exposure (low priority)• Middle and lower lobectomies and subsegmental resections• Esophageal surgery• Thoracic spine procedure• Minimal invasive cardiac surgery (MID-CABG, TMR)

• Postcardiopulmonary bypass status after removal of totally occluding chronic unilateral pulmonary emboli

• Severe hypoxemia due to unilateral lung disease

Page 200: BRONCHIECTASIS

DLT CAUSE RECTIFICATION

Both lungs ventilated-when either lumen ventillated

Too far out Deflate & advance

Both lungs ventilate via bron.lumen,neither when ventillated via tracheal lumen

Br.lumen in trachea/ cuff overinflated

Deflate & advance

No ventillation via bronchial lumen

?entered other side reposition

Upper lobe no ventilation Too far down Deflate & withdraw

Obstructed breathing pattern Herniation of DLT cuff Reduce cuff /change DLT

Page 201: BRONCHIECTASIS

Indications for a Right-Sided Double-Lumen Tube

• Distorted Anatomy of the Entrance of Left Mainstem Bronchus

• External or intraluminal tumor compression

• Descending thoracic aortic aneurysm• Site of Surgery Involving the Left Mainstem

Bronchus• Left lung transplantation• Left-sided tracheobronchial disruption• Left-sided pneumonectomy • Left-sided sleeve resection

Page 202: BRONCHIECTASIS

LUNG ISOLATION

• SINGLE LUMEN ENDOBRONCHIAL TUBES

• Gale&waters• Magill• Machray• Gordon &green• Macintosh &leatherdale• Brompton-pallistor

Page 203: BRONCHIECTASIS

BRONCHIAL BLOCKERS

• MAGILL • CRAFOORD• VERNON THOMPSON• STURTZ BECHER (WITH BLOCKERS)• VELLACOT (FOR UPPERLOBE RT BPF)• GREEN

Page 204: BRONCHIECTASIS

NEWER BLOCKERS

• 1.TORQUE CONTROLLED (UNIVENT)BLOCKER

• FOB GUIDED• 2.ARNDT WIRE GUIDED BLOCKER• NYLON WIRE LOOP PRESENT WITH

FOB• MURPHYS EYE PRESENT• CENTRAL CHANNEL 1.4MM ID

Page 205: BRONCHIECTASIS

• 3.COHEN BLOCKER• WHEEL GUIDED IN DISTAL TIP • MURPHY EYE PRESENT• CENTRAL CHANNEL 1.6 MM ID• 4.FUJI BLOCKER • INDEPENDENT BLOCKER• MADE UP OF SILICON• PRERORMED ANGULATION • NO MURPHY EYE• CENTRAL CHANNEL 2.0 MM ID

Page 206: BRONCHIECTASIS

COHEN BLOCKER

Page 207: BRONCHIECTASIS

FUJI BLOCKER

Page 208: BRONCHIECTASIS

LATEST BRONCHIAL BLOCKER

• EZ BLOCKER• Due to its specific shape the EZ-Blocker®

is easy to place and will also remain in its correct position during manipulation of the patient or lung.

• The EZ-Blocker® is a catheter with a bifurcated distal end. The bifurcation resembles the bifurcation of the trachea. During insertion trough a standard endotracheal tube, both distal ends easily find their way into the two main stem bronchi.

Page 209: BRONCHIECTASIS

FEATURES OF THE EZ-BLOCKER

• Quick and easy positioning- Minimal risk of dislocation during procedure- Optimal lung collapse- In case of postoperative ventilation no re-intubation necessary- Easy handling in case of bilateral procedures

Page 210: BRONCHIECTASIS
Page 211: BRONCHIECTASIS

DLT

• CARLENS • BRYCE SMITH• BRYCE SMITH & SALT(RT SIDED )• WHITE• ROBERTSHAW• BRONCHOCATH • PORTEX

Page 212: BRONCHIECTASIS

DLT

• 2 LUMENS• 2 CUFFS• 2 PILOT TUBES• 2 CURVATURES

• EASY FOR SUCTIONING• RAPID CONVERTION TO TWO LUNG

VENTILATION• CPAP /PEEP TO COLLAPSED LUNG

Page 213: BRONCHIECTASIS

DLT –POSITION PLACEMENT

• AT TEETH 12+(HT/10) CM

• CUFF SEALING- BY WATERSEALING METHOD

Page 214: BRONCHIECTASIS

FOR PEDIATRICS

• LEYLAND RUBBER DLT FOR 6-8 YRS• BRONCHIAL BLOCKERS• MARRAO BILUMEN UNCUFFED TUBE

FOR NEONATES >1500KG,&5 YRS CHILD

• Narukis – trachoeostomy tube

Page 215: BRONCHIECTASIS

COMPLICATIONS

• Traumatic injury to the airway during placement or removal • Hoarseness • Sore throat • Ecchymosis of the mucous membranes • Arytenoid dislocation • Vocal cord rupture • Vocal cord paralysis • Tracheal or bronchial laceration • Tracheobronchial rupture • Pneumothorax • Hemorrhage • Tracheal or bronchial tissue necrosis due to

excessive pressure in the DLET cuffs

Page 216: BRONCHIECTASIS

Factors Affecting Regional HPV• HPV is inhibited directly

by volatile anesthetics (not N20), vasodilators (NTG, SNP, dobutamine, many ß2-agonist), increased PVR (MS, MI, PE) and hypocapnia

• HPV is indirectly inhibited by PEEP, vasoconstrictor drugs (Epi, dopa, Neosynephrine) by preferentially constrict normoxic lung vessels

Page 217: BRONCHIECTASIS

HPV

• LOCAL REFLEX• EDRF-NO MEDIATED• FACTORS INHIBIT HPV• INCREASED CO• VASODILATORS• VOLATILE AGENTS>1 MAC• VASOCONSTRICTORS• CCB• BRONCHODILATORS• BETA 2 AGONISTS

Page 218: BRONCHIECTASIS

FACTORS POTENTIATE HPV

• COX INHIBITORS• NO• BETA BLOCKERS• ALMITRINE

Page 219: BRONCHIECTASIS

PHYSIOLOGY OF THE LDP

• Upright position LDP, lateral decubitus position

• blood flow -RT[55%] ,LT[45%] RT -45% ,LT - 35%

Page 220: BRONCHIECTASIS

INTRAOP GOALS• MINIMIZE ANESTHESIA TIME• CONTROL SECRETIONS• PREVENT ASPIRATION• BRONCHODILATION• INTERMITTENT HYPERINFLATION

Page 221: BRONCHIECTASIS

ANESTHETIC MANAGEMENT

INHALED ANAESTHETICS• ↓ airway irritability• Allows delivery of high FIO2 without

loss of anaesthesia• Rapidly eliminated• Provide CVS stability

COMBINE IV AGENTS WITH INHALATIONAL ANAESTHETICS TO MAINTAIN ANAESTHESIA

Page 222: BRONCHIECTASIS

CHECKING DLT-LT SIDED DLT

• INFLATE TRACHEAL CUFF(5-10ML)• CHECK BAE-IF UNILATERAL BREATH

SOUNDS-TUBE TOO FAR DOWN • INFLATE BRONCHIAL CUFF-1-2 ML• CLAMP TRACHEAL LUMEN • CHECK UNILATERAL LT SIDE BREATH

SOUNDS

1.PERSISTENCE OF RT BREATH SOUND-BRONCHIAL OPENING STILL IN TRACHEA

Page 223: BRONCHIECTASIS

• 2.UNILATERAL RT –INCORRECT ENTRY IN TO RT BRONCHUS

• 3.ABSCENCE OF BREATH SOUNDS OVER ENTIRE LUNG-TUBE IS TOO FAR DOWN IN LT BRONCHUS

• UNCLAMP TRACHEAL LUMEN&CLAMP BRONCHIAL LUMEN

• CHECK FOR RT SIDE-ABSENCE OR DIMINISHED BREATH-TUBE NOT FAR ENOUGH DOWN &BRONCHIAL CUFF OCCLUDING DISTAL TRACHEA(CUFF HERNIATION

Page 224: BRONCHIECTASIS

AIRWAY BLOCKS FOR FOB

Page 225: BRONCHIECTASIS

GLOSSOPHARYNGEAL NERVE BLOCK

• Topical spray• Direct contact of soaked

pledgets• Direct infiltration -

approachesINTRA ORAL PERISTYLOID

Page 226: BRONCHIECTASIS

• INTRAORAL

-Need enough mouth opening.

-Inject submucosally 5ml of LA at

the caudal aspect of posterior tonsillar pillar

• PERISTYLOID APPROACH

-Position- supine

-A line is drawn from angle of mandible & mastoid process

Page 227: BRONCHIECTASIS

PERISTYLOID APPROACH

• Styloid process palpated just posterior to angle of jaw along this line

• A short small gauge needle seated against styloid

• Needle is then withdrawn directed posteriorly

• Then 5 to 7 ml of la injected after negative aspiration

• In both approaches care to be taken not to injure internal carotid artery

Page 228: BRONCHIECTASIS

SUPERIOR LARYNGEAL NERVE BLOCK

• Its internal branch arises lateral to greater cornu of hyoid bone

• Passes about 2-4 mm inferior to greater cornu

• Then pierces the thyrohyoid membrane

• Travels under the mucosa of pyriform fossa

Page 229: BRONCHIECTASIS

SUPERIOR LARYNGEAL NERVE BLOCK

In the pyriform fossa By using kraus or

jacksons forceps Hold a pledget of

cotton soaked in 2 to 4% against the mucosa for about 60 sec

External approach Direct infiltration by a

25 G needle at the level of thyrohyoid membrane inferior to greater cornu of hyoid bone

Page 230: BRONCHIECTASIS

RECURRENT LARYNGEAL NERVE BLOCK

• Translaryngeal block of RLN is accomplished at level of CRICOTHYROID MEMBRANE

• A 10 ml syringe with 22 or 20 gauge needle is advanced until air is aspirated

• 4 ml of 4% lignocaine injected, inducing cough which disperses it

Page 231: BRONCHIECTASIS

ANTERIOR ETHMOIDAL NERVE BLOCK

Page 232: BRONCHIECTASIS

MANAGEMENT OF OLV...

Initial management of OLV anesthesia:• Maintain two-lung ventilation as long as

possible• Use FIO2 = 1.0• Tidal volume, 10 ml/kg (8-12 ml/kg)• Adjust RR (increasing 20-30%) to keep PaCO2

= 40 mmHg• No PEEP (or very low PEEP, < 5 cm H2O)• Continuous monitoring of oxygenation and

ventilation (SpO2, ABG and ET CO2)

Page 233: BRONCHIECTASIS

THERAPIES FOR DESATURATION DURING ONE-LUNG VENTILATION

• Severe or precipitous desaturation: Resume Severe or precipitous desaturation: Resume two-lung ventilation (if possible).two-lung ventilation (if possible).Gradual desaturation:Gradual desaturation:

• Fio2 1.0.Fio2 1.0.•     Check position of double-lumen tube or Check position of double-lumen tube or

blocker with fiberoptic bronchoscopy.blocker with fiberoptic bronchoscopy.•     Ensure that cardiac output is optimal; Ensure that cardiac output is optimal;

decrease volatile anesthetics to < 1 MAC. decrease volatile anesthetics to < 1 MAC. •   Apply a recruitment maneuver to the Apply a recruitment maneuver to the

ventilated lung (this will transiently make the ventilated lung (this will transiently make the hypoxemia worse)hypoxemia worse)

Page 234: BRONCHIECTASIS

• Apply PEEP 5 cm H2O to the ventilated lung • Apply CPAP 1-2 cm H2O to the nonventilated lung

(apply a recruitment maneuver to this lung immediately before CPAP). 

• Intermittent reinflation of the nonventilated lung • Partial ventilation techniques of the nonventilated

lung:   a.    Oxygen insufflation  b.    High-frequency ventilation  c.    Lobar collapse (using a bronchial blocker) 

• Mechanical restriction of the blood flow to the nonventilated lung

Page 235: BRONCHIECTASIS

OTHER MODE OF VENTILATION

• HIGH FREQ VENTILATION • 2 ML/KG• RR -60-2400 BREATHS/MIN• APNEIC INSUFFLATION

Page 236: BRONCHIECTASIS

POSTOP GOALS• CONTINUE PREOPERATIVE

MEASURES• MOBILIZE SECRETIONS• EARLY AMBULATION• COUGH & DEEP BREATHING• ANALGESIA

Page 237: BRONCHIECTASIS

POST OP COMPLICATIONS

• HERNIATION OF HEART• PULMONARY TORSION• MASSIVE HEMMARRAHGE• BRONCHIAL DISRUPTION• RESP INSUFFICIENCY• UNILATERAL NEGATIVE PRESSURE

PULMONARY EDEMA• RHF• RT TO LT SHUNT THRO PATENT

FORAMEN OVALE• NEURAL INJURIES

Page 238: BRONCHIECTASIS

POST OP PAIN RELIEF

• CRYO ANALGESIA• EPIDURAL• INTERPLEURAL • PARAVERTEBRAL BLOCK